Oxidized derivatives of triazolylpurine useful as ligands for adenosine A2A receptors and their use as drugs

摘要

The present invention relates to new triazolyl purine derivatives of formula (I), processes for their preparation, and to pharmaceutical compositions containing them for the treatment of neurological disorders or cerebral ischaemia for which inhibition of adenosine A2A receptor will result at improving the health state of a patient.